Crossmark

Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

Crossref DOI link: https://doi.org/10.1186/s12891-018-2151-2

Published Online: 2018-07-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Yong Tae

Kang, Min Wook

Lee, Joon Kyu

Lee, Young Min

Kim, Joong Il http://orcid.org/0000-0003-1154-3652
Funding

Funding for this research was provided by:

Hallym University Medical Center (HURF-2017-47)
License Information

Text and Data Mining valid from 2018-07-18
More Information

Article History

Received: 15 March 2018

Accepted: 21 June 2018

First Online: 18 July 2018

Ethics approval and consent to participate

: This study was approved by the Hallym University Kangnam Sacred Heart Hospital Institutional Review Board (IRB number: HUKSHH IRB 2017–10-010). Informed consent was waivered by the above IRB as the present retrospective cohort study involved already existing data and records at the time of investigation, and did not retain personal identifiers of the gathered information.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below